Christopher Bunker

Company: Alamar Biosciences Inc.

Job title: Vice President - Biopharma Business Development

Seminars:

Panel Discussion: Multiomics, Longitudinal Data & Precision Medicine in the CNS: How Can we Get the Most Out of the Tools at Our Disposal? 9:00 am

Harnessing proteomics to identify early signatures of risk factors for neurodegenerative and neuroinflammatory disease Redefining disease heterogeneity with discrete biomarker populations Building up a network of internal and external capabilities to get the most out of complex patient data, producing quantitative biological insightsRead more

day: Conference Day One